Subacute Combined Degeneration

Links shared publicly online about this topic

Radiation and Lucentis Combined to Treat Macular Degeneration

retinaeyedoctor.com — “External beam radiation combined with Lucentis for wet macular degeneration may reduce the frequency of anti-VEGF injections.View full resource at retinaeyedoctor.com

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 3:19 pm By:

Combination therapy reduces re-treatment burden in wet AMD patients

osnsupersite.com — “VANCOUVER, British Columbia — Combination therapies generated greater visual acuity gains with fewer reinjections compared with monotherapyView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on June 23, 2010 at 3:48 pm By:

OSNSuperSite The OSN SuperSite Health News

Combination therapy reduces re-treatment burden in wet AMD patients: http://ht.ly/22hlo

2 years ago...

QLT reports positive 12-month results for trial of AMD combination therapy

osnsupersite.com — “VANCOUVER, British Columbia — QLT has announced positive 12-month results from its phase 2 RADICAL study, according to a press release from the cView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on June 3, 2009 at 2:58 pm By:

OSNSuperSite The OSN SuperSite Health News

QLT reports positive 12-month results for trial of AMD combination therapy: http://ow.ly/aQYK

3 years ago...

PDGF agent may offer promise in combination therapy for CNV secondary to AMD

osnsupersite.com — “KOLOA, Hawaii " A novel platelet-derived growth factor currently being studied in clinical trials may boost the effect of anti-VEGF therapy and providView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on January 20, 2010 at 3:58 pm By:

OSNSuperSite The OSN SuperSite Health News

#OSNhe10 — PDGF agent may offer promise in combination therapy for CNV secondary to AMD: http://ow.ly/YBWe

2 years ago...

05-25-2010 - A Retina Eye Blog - May 25, 2010 Radiation and Lucentis Combined to Treat Macular Degeneration

aweber.com — “05-25-2010 - A Retina Eye Blog - May 25, 2010 Radiation and Lucentis Combined to Treat Macular DegenerationView full resource at aweber.com

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 4:03 pm By:

retinadoc Randall Wong, MD Surgeon, Ophthalmologist, Physician, and Doctor

A Retina Eye Blog - Radiation and Lucentis Combined to Treat Macular Degeneration http://aweber.com/b/x7-j

2 years ago...

A combination of nutrients improves age-related macular degeneration. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine

greenmedinfo.com — “This article on GreenMedInfo.com concerns - Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.View full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on June 28, 2011 at 6:12 pm By:

New treatment for wet macular degeneration

eyedocnews.com — “PDGF aptamer combined with Lucentis® may have significant effects on choroidal neovascularizationView full resource at eyedocnews.com

  • View Related
  • Share

Most Recently Shared on August 13, 2009 at 1:39 am By:

eyedocnews Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician

Discuss: Anti-Pericyte Aptamer May Be Effective Against CNV: By Dr. Randall WongAs reported by David S. .. http://bit.ly/WE8HQ

3 years ago...

Ophthotech Enrolls Its First Patient In A Randomized, Controlled Phase II Study Of E10030 In Macular Degeneration

medicalnewstoday.com — “Ophthotech Corp. (Ophthotech), a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, announced that the first patient has been enrolView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 28, 2010 at 2:11 pm By:

mnt_eyehealth MNT Eye Health Health News

Ophthotech Enrolls Its First Patient In A Randomized, Controlled Phase II Study Of E10030 In Macular Degeneration http://mnt.to/3BQp

2 years ago...

Combined PDT-intravitreal bevacizumab reduces pigment epithelial detachment

osnsupersite.com — “Photodynamic therapy and adjunctive intravitreal bevacizumab minimized pigment epithelial detachment associated with age-related macular degeneration,View full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on June 22, 2009 at 3:11 pm By:

OSNSuperSite The OSN SuperSite Health News

Combined PDT-intravitreal bevacizumab reduces pigment epithelial detachment: http://ow.ly/fvY7

3 years ago...

New Study Finds Combination Diet Effective in Reducing ARMD

eyedocnews.com — “Another data analysis from the AREDS study finds that certain foods combined with a low glycemic index diet may reduce macular degeneration.View full resource at eyedocnews.com

  • View Related
  • Share

Most Recently Shared on May 3, 2009 at 10:52 pm By:

eyedocnews Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician

Discuss: AREDS Analysis Finds Combination of Dietary Factors Decreases ARMD: As reported in the May issu.. http://tinyurl.com/cl6w79

3 years ago...

MacuCLEAR, Mystic announce positive results of clinical trial for AMD treatment system

osnsupersite.com — “PLANO, Texas — A combined age-related macular degeneration solution and drug delivery system showed promising results in a phase 1b clinical triaView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on October 9, 2009 at 8:33 pm By:

OSNSuperSite The OSN SuperSite Health News

MacuCLEAR, Mystic announce positive results of clinical trial for AMD treatment system http://ow.ly/tCTt

3 years ago...

Ophthotech closes $30 million in funding to support phase 2 trial of AMD treatment

osnsupersite.com — “NEW YORK — Ophthotech has received $30 million in Series B financing to support a phase 2 combination trial of E10030, the company's lead productView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on December 16, 2009 at 4:05 pm By:

OSNSuperSite The OSN SuperSite Health News

Ophthotech closes $30 million in funding to support phase 2 trial of AMD treatment: http://ow.ly/MHXZ — #ophthalmology #business #news

2 years ago...

Triamcinolone, PDT may be useful for AMD patients who cannot receive anti-VEGF therapy

osnsupersite.com — “Combined triamcinolone acetonide and photodynamic therapy may help stabilize vision in patients with age-related exudative macular degeneration and maView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on November 11, 2009 at 3:58 pm By:

OSNSuperSite The OSN SuperSite Health News

Triamcinolone, PDT may be useful for AMD patients who cannot receive anti-VEGF therapy: http://ow.ly/Bn9Y

3 years ago...

IOL telescope system offers potential for functional vision in patients with severe end-stage AMD

osnsupersite.com — “BOSTON — A combination of an anterior chamber IOL and posterior chamber IOL that functions like a Galilean telescope offers reasonable visual recView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on April 12, 2010 at 2:15 pm By:

OSNSuperSite The OSN SuperSite Health News

#ASCRS - IOL telescope system offers potential for functional vision in patients with severe end-stage AMD: http://ow.ly/1xnM7

2 years ago...

Bayer HealthCare - VEGF Trap-Eye Submitted for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration in Japan

press.bayerhealthcare.com — “Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry. The company combines the global activities of the divisions Animal Health, Bayer Schering Pharma, Consumer Care and Diabetes Care. More than 50,000 people are employed by Bayer HealthCare worldwide. Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality View full resource at press.bayerhealthcare.com

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 7:14 am By:

BayerHealthCare Bayer HealthCareNews Pharma

VEGF Trap-Eye Submitted for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration in Japan http://t.co/9dEbzKz

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390